Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$227.97−4.26 (-1.83%)
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher Life Sciences by Year
Life Sciences — Acquisitions Impact (including Abcam acquisition, annual series) (%)
Danaher Life Sciences: -0.5% in FY2025, up 5.5 pts from a year earlier.
Latest, FY2025
-0.5%
Period ended Dec 31, 2025
Change on a year earlier
+5.5 pts
-6.0% in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below
Where the FY2025 figure comes from
Source: Danaher IR — nongaap_2025Q4 ↗
Reported in Danaher Non-GAAP Reconciliations & Supplemental Data (8-K / IR PDF).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Life Sciences — Acquisitions Impact (including Abcam acquisition, annual series) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -0.5% | +5.5 pts | Danaher IR — nongaap_2025Q4 ↗ |
| FY2024 | Dec 31, 2024 | -6.0% | -4.5 pts | Danaher IR — nongaap_2024Q4 ↗ |
| FY2023 | Dec 31, 2023 | -1.5% | +4.0 pts | Danaher IR — nongaap_2023Q4 ↗ |
| FY2022 | Dec 31, 2022 | -5.5% | – | Danaher IR — nongaap_ex_veralto ↗ |
Cite this data
StockData. (2026). Danaher Life Sciences (%), annual FY2022–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ma-sales-impact-lifesci
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.